Maravai LifeSciences Reports Q3 2026 Financial Results

Maravai LifeSciences reported third-quarter 2026 revenue of $45.9 million, above the FactSet consensus estimate of $43.6 million. Its adjusted loss was $0.03 per share, narrower than the estimated loss of $0.06 per share.